Capricor shares four-year data showing Deramiocel slowed DMD progression and preserved function, with maintained safety in long-term use.

Capricor Therapeutics (NASDAQ:CAPR) lost ~15% on Friday after the cell therapy developer posted long-term data from an ...

Sarepta shares face pressure after a second Elevidys-linked death and analyst downgrade over safety concerns and lowered ...

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

Travis Kelce and Patrick Mahomes hosted Make-A-Wish kids at Kansas City Chiefs practice, offering gifts and unforgettable ...

Skeletal muscle disease progression continues to slow with extended treatment (PUL v2.0) ...

Caregiving means that columnist Betty Vertin sometimes misses out on activities with her children who don't have DMD. Finding balance is key.

New York Yankees captain Aaron Judge is one of the scariest hitters in the league but not the scariest on the team, according ...